Skip to main content
Caplight Logo









MediPines

MediPines

Private
Yorba Linda, CaliforniaHealthcare & Life Scienceshttps://medipines.com

Last Round

Grant

Jul 24, 2020

Total Funding Raised

$50,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

MediPines operates in Healthcare & Life Sciences and is based in Yorba Linda, California. Its latest recorded funding round was a Grant round in July 2020.

MediPines is a medical technology company that develops non-invasive respiratory and cardiovascular diagnostic devices, including its flagship AGM100 system.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

MediPines Comparables

Compare MediPines with similar companies based on industry and business-model similarity.

MediPines comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Niterra Co., Ltd.
76%
Nonin Medical
71%
Masimo Corporation
69%
Book a demo to see all comparables

For institutional investors. Book with your work email.

MediPines Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 24, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

MediPines Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 42% MoM.

  • Jan 20, 2026

    Monthly visitors increased 47% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

MediPines Filings

Explore SEC and related filing metadata, where available.

MediPines filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about MediPines's valuation, stock price, and market status.

Is MediPines a public or private company?

MediPines is a private company.

What is the current stock price of MediPines?

MediPines is a private company, so its shares have no public market price. Caplight tracks MediPines's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is MediPines worth (valuation)?

Valuation information for MediPines is not publicly available.

Can I buy MediPines stock?

MediPines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was MediPines's last funding round?

MediPines's most recent funding round was Grant on July 24, 2020.

Who are the main investors in MediPines?

Key investors in MediPines include National Capital Consortium for Pediatric Device Innovation.

Will MediPines IPO soon?

No public IPO plans have been announced for MediPines.

How can I track MediPines secondary market activity?

Caplight tracks bids, offers, and trades in MediPines's shares on secondary markets.

Firmographic Details

HeadquartersYorba Linda, California
Employee Range12
Year Founded2013
Last FundingJul 24, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?